Conformis Near-Term Growth Hinges on Intellectual Property

Conformis logo

Conformis reported 1Q21 orthopedic revenue of USD $13.8 million, -16% vs. 1Q20. The company remains impacted by COVID’s impact on the knee replacement market, and it pointed to the abnormally high levels of deferred knee replacements over the last 12 months compared to other surgeries.

The company expects second quarter product revenue of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us